Christina Shafer's most recent trade in Marinus Pharmaceuticals Inc was a trade of 3,820 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on Aug. 5, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Marinus Pharmaceuticals Inc | Christina Shafer | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.14 per share. | 05 Aug 2024 | 3,820 | 67,406 (0%) | 0% | 1.1 | 4,355 | Common Stock |
Marinus Pharmaceuticals Inc | Christina Shafer | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 49,125 | 49,125 | - | - | Stock Option (Right to Buy) | |
Marinus Pharmaceuticals Inc | Christina Shafer | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 10,918 | 71,226 (0%) | 0% | 0 | Common Stock | |
Marinus Pharmaceuticals Inc | Shafer Christina | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 9.56 per share. | 20 Feb 2024 | 2,153 | 60,308 (0%) | 0% | 9.6 | 20,583 | Common Stock |
Marinus Pharmaceuticals Inc | Shafer Christina | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 98,250 | 98,250 | - | - | Stock Option (Right to Buy) | |
Marinus Pharmaceuticals Inc | Christina Shafer | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 21,835 | 62,461 (0%) | 0% | 0 | Common Stock | |
Marinus Pharmaceuticals Inc | Christina Shafer | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 9.52 per share. | 07 Aug 2023 | 2,385 | 40,637 (0%) | 0% | 9.5 | 22,705 | Common Stock |
Marinus Pharmaceuticals Inc | Christina Shafer | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 8.91 per share. | 07 Aug 2023 | 11 | 40,626 (0%) | 0% | 8.9 | 98 | Common Stock |
Marinus Pharmaceuticals Inc | Christina Shafer | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 78,188 | 78,188 | - | - | Stock Option (Right to Buy) | |
Marinus Pharmaceuticals Inc | Christina Shafer | CHIEF COMMERCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 17,375 | 43,022 (0%) | 0% | 0 | Common Stock | |
Marinus Pharmaceuticals Inc | Christina Shafer | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.70 per share. | 09 Nov 2022 | 1,505 | 25,647 (0%) | 0% | 4.7 | 7,074 | Common Stock |